Epidemiology and Immune Pathogenesis of Viral Sepsis
Open accessAbstract
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Sepsis can be caused by a broad range of pathogens; however, bacterial infections represent the majority of sepsis cases. Up to 42% of sepsis presentations are culture negative, suggesting a non-bacterial cause. Despite this, diagnosis of viral sepsis remains very rare. Almost any virus can cause sepsis in vulnerable patients (e.g., neonates, infants, and other immunosuppressed groups). The prevalence of viral sepsis is not known, nor is there enough information to make an accurate estimate. The initial standard of care for all cases of sepsis, even those that are subsequently proven to be culture negative, is the immediate use of broad-spectrum antibiotics. In the absence of definite diagnostic criteria for viral sepsis, or at least to exclude bacterial sepsis, this inevitably leads to unnecessary antimicrobial use, with associated consequences for antimicrobial resistance, effects on the host microbiome and excess healthcare costs. It is important to understand non-bacterial causes of sepsis so that inappropriate treatment can be minimised, and appropriate treatments can be developed to improve outcomes. In this review, we summarise what is known about viral sepsis, its most common causes, and how the immune responses to severe viral infections can contribute to sepsis. We also discuss strategies to improve our understanding of viral sepsis, and ways we can integrate this new information into effective treatment.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Immunocompromised patients, including those with neutropenia, HIV, haematological malignancies, stem cell or solid organ transplants, are particularly vulnerable to viral infections, and certain viruses can cause severe disease.
“Immunocompromised patients are particularly vulnerable to viral infections, including patients with neutropenia, human immunodeficiency virus (HIV) infection, haematological malignancies and haematopoietic stem cell transplantation or solid organ transplants”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [229]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 288 · Cited by 351
- Authors
- Lin, G.-L., McGinley, J. P., Drysdale, S. B., & Pollard, A. J.
- Affiliations
- National Institute for Health and Care Research (GB)
- St George’s University Hospitals NHS Foundation Trust (GB)
- Corresponding author
- Lin, Gu-Lung
- McGinley, Joseph P.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-09-27
- Volume
- 9
- Pages
- 2147-2147
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC6170629
- OpenAlex
- W2894422883
- Cited by
- 351
- References
- 288
- Citations by year
- 2026: 21 · 2025: 32 · 2024: 40 · 2023: 70 · 2022: 54 · 2021: 69 · 2020: 50 · 2019: 13 · 2018: 1
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- European Federation of Pharmaceutical Industries and Associations (116019)
- National Institute for Health and Care Research (NF-SI-0617-10036, 116019, CL-2014-13-001)
- European Commission (116019, HORIZON2020)
- Innovative Medicines Initiative (116019)
- Topics
- Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- viral sepsis, sepsis, immune pathogenesis, culture-negative sepsis, broad-spectrum antibiotic use, antimicrobial resistance, host microbiome, severe viral infections, immunocompromised patients, neonates, sepsis treatment
- MeSH terms
- Global Burden of Disease, Anti-Bacterial Agents, Antiviral Agents, Humans, Viremia, Viruses, Prevalence, Immunocompromised Host
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review